Cingulate Inc.
Company Information
Industry Pharmaceutical Preparations
SIC Code 2834
Entity Type operating
SEC Category Emerging growth company
State of Incorporation DE
Business Address 1901 W. 47TH PLACE, KANSAS CITY, KS, 66205
Mailing Address 1901 W. 47TH PLACE, KANSAS CITY, KS, 66205
Phone (913) 942-2300
Fiscal Year End 1231
EIN 863825535
Financial Overview
FY2024
$3.49M
Total Assets
$10.36M
Total Liabilities
$7.46M
Stockholders' Equity
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 4 Insider stock transaction report | February 10, 2026 | View on SEC |
| 4 Insider stock transaction report | February 10, 2026 | View on SEC |
| 4 Insider stock transaction report | February 10, 2026 | View on SEC |
| 4 Insider stock transaction report | February 10, 2026 | View on SEC |
| SCHEDULE 13D Beneficial ownership report (>5%) | February 9, 2026 | View on SEC |
| 8-K Current report of material events | February 6, 2026 | View on SEC |
| 8-K Current report of material events | January 28, 2026 | View on SEC |
| 8-K Current report of material events | January 15, 2026 | View on SEC |
| S-3 Shelf registration for future offerings | January 12, 2026 | View on SEC |
| 424B5 Prospectus supplement | January 12, 2026 | View on SEC |
Material Events
8-K Leadership Change December 15, 2025
High Impact
- Cingulate Inc. CEO Dr. Shane Schaffer has returned to his role after being on administrative leave since August.
- Dr. Schaffer's leave was due to a personal legal matter, which is now resolved; he pleaded 'no contest' to a misdemeanor and received 12 months probation.
Insider Trading
BUY 4 insiders
4 recent transactions
View Full Insider Trading Profile
Related Companies
Companies in the same industry (SIC: 2834)
Werewolf Therapeutics, Inc.
HOWL Pharmaceutical Preparations
Zenas BioPharma, Inc.
ZBIO Pharmaceutical Preparations
Centessa Pharmaceuticals plc
CNTA Pharmaceutical Preparations
Karyopharm Therapeutics Inc.
KPTI Pharmaceutical Preparations
VERTEX PHARMACEUTICALS INC / MA
VRTX Pharmaceutical Preparations
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.